Navigation Links
Talecris Biotherapeutics to Report First Quarter 2010 Financial Results

RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its first quarter 2010 financial results on April 28, 2010, after the stock market closes and will host a conference call at 8:30 a.m. Eastern Time on April 29, 2010.

Investors and analysts may participate via phone by calling 1-888-713-4205 (domestic) or 1-617-213-4862 (international), pass code number 21563385. To ensure timely access, please dial into the call approximately 10 minutes before it is scheduled to begin. The listen-only webcast will also be available through the investor relations section of

Participants may pre-register for the conference call at: Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection.

A replay of the conference call will be available beginning approximately two hours after the call concludes and will remain accessible until May 6, 2010, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), pass code number 40214869. The webcast of the conference call will be archived on the investor relations section of

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonology, neurology and hemostasis. For more information, please visit:

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
2. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
3. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
4. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
5. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
6. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
7. Oxford BioTherapeutics Appoints Michael Moore as Chairman
8. Oxygen Biotherapeutics, Inc. Expands Board of Directors
9. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
Post Your Comments:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):